AdaptHealth Corp. (NASDAQ:AHCO) Receives $11.67 Consensus Price Target from Analysts

Shares of AdaptHealth Corp. (NASDAQ:AHCO - Get Free Report) have been given a consensus rating of "Moderate Buy" by the six brokerages that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $11.67.

AHCO has been the topic of a number of analyst reports. Robert W. Baird lowered their price target on AdaptHealth from $16.00 to $14.00 and set an "outperform" rating on the stock in a research report on Wednesday, November 6th. Truist Financial dropped their target price on shares of AdaptHealth from $13.00 to $12.00 and set a "buy" rating for the company in a research report on Friday, November 15th. UBS Group reduced their price target on shares of AdaptHealth from $13.00 to $12.00 and set a "buy" rating on the stock in a research report on Wednesday, November 6th. Royal Bank of Canada dropped their price objective on shares of AdaptHealth from $13.00 to $11.00 and set an "outperform" rating for the company in a report on Tuesday, November 19th. Finally, Canaccord Genuity Group reduced their target price on AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a report on Wednesday, November 6th.

Insiders Place Their Bets

In other AdaptHealth news, COO Shaw Rietkerk sold 25,000 shares of the stock in a transaction on Friday, September 20th. The stock was sold at an average price of $11.24, for a total value of $281,000.00. Following the transaction, the chief operating officer now directly owns 212,611 shares in the company, valued at approximately $2,389,747.64. This trade represents a 10.52 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 4.43% of the company's stock.

Hedge Funds Weigh In On AdaptHealth

Several large investors have recently made changes to their positions in the company. Franklin Resources Inc. raised its stake in shares of AdaptHealth by 20.2% during the third quarter. Franklin Resources Inc. now owns 65,601 shares of the company's stock worth $737,000 after buying an additional 11,037 shares during the last quarter. Geode Capital Management LLC grew its holdings in AdaptHealth by 12.2% during the 3rd quarter. Geode Capital Management LLC now owns 2,451,173 shares of the company's stock worth $27,532,000 after acquiring an additional 265,712 shares during the period. Barclays PLC grew its holdings in AdaptHealth by 361.3% during the 3rd quarter. Barclays PLC now owns 181,240 shares of the company's stock worth $2,034,000 after acquiring an additional 141,949 shares during the period. LRI Investments LLC raised its position in shares of AdaptHealth by 32.0% during the 3rd quarter. LRI Investments LLC now owns 15,331 shares of the company's stock valued at $172,000 after acquiring an additional 3,713 shares during the last quarter. Finally, Virtus Investment Advisers Inc. acquired a new position in shares of AdaptHealth in the 3rd quarter valued at $346,000. Institutional investors and hedge funds own 82.67% of the company's stock.

AdaptHealth Price Performance

Shares of AdaptHealth stock traded up $0.04 during trading on Friday, hitting $10.03. 486,669 shares of the company's stock traded hands, compared to its average volume of 1,128,115. The company has a market cap of $1.35 billion, a PE ratio of -6.08, a PEG ratio of 1.41 and a beta of 1.11. The firm's fifty day moving average price is $10.36 and its 200 day moving average price is $10.47. AdaptHealth has a twelve month low of $6.43 and a twelve month high of $11.90. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00.

AdaptHealth (NASDAQ:AHCO - Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The company reported $0.15 earnings per share for the quarter, missing analysts' consensus estimates of $0.17 by ($0.02). AdaptHealth had a negative net margin of 6.57% and a positive return on equity of 9.62%. The company had revenue of $805.90 million for the quarter, compared to analyst estimates of $809.32 million. During the same period in the previous year, the firm posted $0.19 earnings per share. The firm's revenue for the quarter was up .2% compared to the same quarter last year. Analysts forecast that AdaptHealth will post 0.88 earnings per share for the current year.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.